Conclusions: Promoting biotechnology innovation in developing countries
Article Abstract:
Several factors that encourage successful development, and several common challenges that countries share in continuing and sustaining development of healthcare biotechnology are identified. The various lessons learned including ways to promote health biotechnology in developing countries such as political will, individual leadership, close linkages, enterprise creation, and intellectual property are highlighted.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Biotechnology and the UN's millennium development goals
Article Abstract:
The 189 member states of United Nations have committed to achieve the Millennium Development Goals (MDGs) by 2015. The MDGs are aimed at poverty reduction, improved education and health, and environmental sustainability and also, an attempt is made to compare directly biotechnology solutions with development goals.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Introduction: Promoting global health through biotechnology
Article Abstract:
The importance of studying health biotechnology innovation systems in developing countries is addressed using case studies of seven countries. The lessons that can be applied in developing countries and, which can be useful for industrially advanced countries are highlighted.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Competition among trading venues: information and trading on electronic communications networks. Liquidity externalities and adverse selection: evidence from trading after hours
- Abstracts: The number on biotech indexes. Putting biotech risk in its place. Going short on biotech
- Abstracts: Canada's bumper biotech budget. Angel investors shy away from biotech
- Abstracts: Politics torpedo biotech as EU priority. Taiwan: biotech vision. Germany biotech gets second chance
- Abstracts: Edmund D. Pellegrino. DNA vaccines-back in the saddle again?